Multiple Myeloma Research Review, Issue 62
In this issue:
DREAMM-7: Belantamab mafodotin bests daratumumab in RRMM
Front-line extended dosing belamaf + IMiD combo safe in transplant-ineligible disease
Daratumumab + VCd may be a front-line option for transplant-ineligible MM
CASSIOPEIA: PFS benefit to daratumumab in induction, consolidation and maintenance
EVIDENCE – is 12-month MRD status a valid surrogate for survival?
Baseline immune fitness impacts response to teclistamab
Antigen escape is a shared mechanism of resistance to BCMA-directed therapies
Efficacy and safety of factor Xa inhibitors vs warfarin in patients on IMiD therapy
Improvements in outcomes after ASCT over the last 30 years
Expert contributor
Dr Adam Bryant
Adam is a Senior Staff Specialist Haematologist at Liverpool Hospital in South West Sydney and is proud to be affiliated as a Conjoint Senior Lecturer with the University of New South Wales. More broadly, Adam is current Treasurer and NSW Councillor of the Haematology Society of Australia and New Zealand, which is involved in advocacy […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.